Spexis

Switzerland
Allschwil, Basel-Landschaft, Switzerland, CH-4123

Company profile

Spexis company profile

Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. Polyphor was founded in 1996 and is a clinical stage, privately held Swiss specialty pharma company, based in Allschwil near Basel. It focuses on the development of macrocycle drugs that address antibiotic resistance and severe respiratory diseases.

Business identity

Contact email
[email protected]
Phone number
41615671601
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
1996-01-01, Year

Headquarters

Postal code
CH-4123
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
11
Total equity funding
$62.3M
Last funding
Post IPO Debt / $2.5M / 2023-08-15
Last equity funding
Post IPO Equity / $4.5M
Investors
6
Lead investors
4
Founders
2
Articles
63
Exited on
2018-05-15

Founders and investors

Founders

Daniel ObrechtJean-Pierre Obrecht

Lead investors

CARB-XCystic Fibrosis FoundationRepair Impact FundSPRIM Global Investments

Investors

CARB-XCystic Fibrosis FoundationNovartis Venture FundRepair Impact FundSPRIM Global Investments